Labiana Health S.A. Total Assets
Labiana Health S.A. total assets. Based on the latest financial reports, Labiana Health S.A. (LAB) holds total assets worth €57.54 Million EUR (≈ $67.27 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Labiana Health S.A. market cap and net worth for the company's overall valuation and market capitalisation.
Total Assets of Labiana Health S.A. (2021–2025)
Total assets of Labiana Health S.A. from 2021 to 2025. This chart illustrates how Labiana Health S.A.'s total assets have evolved over time, based on quarterly financial data. See LAB share price today for real-time trading data and today's change.
Labiana Health S.A. - Asset Composition Analysis
Labiana Health S.A. Total Assets Breakdown (December 2025)
Labiana Health S.A. total assets breakdown as of December 2025. Labiana Health S.A.'s total assets of €57.54 Million consist of 54.8% current assets and 45.2% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 10.3% |
| Accounts Receivable | €10.39 Million | 18.1% |
| Inventory | €12.03 Million | 20.9% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €6.19 Million | 10.8% |
| Goodwill | €-0.01 | 0.0% |
Asset Composition Trend (2021–2025)
This chart illustrates how Labiana Health S.A.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore LAB working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Labiana Health S.A.'s current assets represent 54.8% of total assets in 2025, an increase from 43.0% in 2021.
- Cash Position: Cash and equivalents constituted 10.3% of total assets in 2025, up from 4.8% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 10.0% of total assets, a decrease from 17.0% in 2021.
- Asset Diversification: The largest asset category is inventory at 20.9% of total assets.
Labiana Health S.A. Competitors by Total Assets
Key competitors of Labiana Health S.A. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
GALDERMA GROUP AG
NYSE:GALDY
|
USA | $13.39 Billion |
|
Takeda Pharmaceutical Company Limited
F:TKDA
|
Germany | €15.41 Trillion |
|
Galderma Group N
SW:GALD
|
Switzerland | CHF12.88 Billion |
|
Enzymatica publ AB
ST:ENZY
|
Sweden | Skr149.24 Million |
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
|
China | CN¥13.98 Billion |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566
|
China | CN¥17.01 Billion |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518
|
China | CN¥13.68 Billion |
|
Walvax BioTech
SHE:300142
|
China | CN¥10.50 Billion |
Labiana Health S.A. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.39 | 1.30 | 1.06 |
| Quick Ratio | 0.86 | 0.84 | 0.59 |
| Cash Ratio | 0.00 | 0.00 | 0.16 |
| Working Capital | €8.87 Million | €6.54 Million | €2.08 Million |
Labiana Health S.A. - Advanced Valuation Insights
This section examines the relationship between Labiana Health S.A.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 10.02 |
| Latest Market Cap to Assets Ratio | 0.79 |
| Asset Growth Rate (YoY) | 10.7% |
| Total Assets | €57.54 Million |
| Market Capitalization | $45.42 Million USD |
Valuation Analysis
Below Book Valuation: The market values Labiana Health S.A.'s assets below their book value (0.79x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Labiana Health S.A.'s assets grew by 10.7% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Labiana Health S.A. (2021–2025)
The table below shows the annual total assets of Labiana Health S.A. from 2021 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €57.54 Million ≈ $67.27 Million |
+10.66% |
| 2024-12-31 | €52.00 Million ≈ $60.80 Million |
-12.05% |
| 2023-12-31 | €59.12 Million ≈ $69.12 Million |
-2.72% |
| 2022-12-31 | €60.78 Million ≈ $71.06 Million |
-11.10% |
| 2021-12-31 | €68.37 Million ≈ $79.93 Million |
-- |
About Labiana Health S.A.
Labiana Health, S.A. develops, manufactures, sells, and markets animal and human health medicine products in Spain, rest of European Union, North America, and internationally. It offers anesthetics-sedatives, anti-infectives, anti-inflammatories, antiparasitics, hormonals, nutritional products, metabolism regulators, and vitamin products. The company also provides sterile and lyophilized dosage f… Read more